Literature DB >> 30799424

Association of Thyrotropin Concentration with Chronic Kidney Disease in a Japanese General Population Cohort.

Akiko Toda1,2, Shigeko Hara3,4, Masayuki Kato3,4, Hiroshi Tsuji3,4, Yasuji Arase3,4.   

Abstract

BACKGROUND: Previous studies have indicated an association between hypothyroidism and kidney dysfunction; however, few studies have investigated whether thyroid dysfunction is a risk factor for chronic kidney disease (CKD) development. And their result is not consistent.
OBJECTIVES: We evaluated the association of thyroid dysfunction with CKD prevalence and development by a multivariate logistic regression analysis.
METHOD: In cross-sectional and longitudinal studies, 16,390 subjects and 7,609 subjects, respectively, who underwent annual health check-ups were analyzed. We categorized the subjects into the following 4 groups based on their serum thyrotropin (TSH) -concentrations: below-normal (TSH < 0.54 mU/L), lower-normal -(0.54-2.40 mU/L), higher-normal (2.41-4.26 mU/L) and above-normal (> 4.26 mU/L). Subjects with eGFR <60 mL/min/1.73 m2 were determined to have CKD.
RESULTS: The cross-sectional study revealed a positive correlation between TSH concentration and CKD -prevalence. Compared with the lower-normal TSH group, the ORs and 95% CIs of CKD prevalence were 0.61 (0.45-0.82, p = 0.001) for the below-normal group, 1.49 (1.33-1.67, p < 0.001) for the higher-normal group, and 1.90 (1.57-2.30, p < 0.001) for the above-normal group. The longitudinal study revealed that the risk of CKD development within 3 years was significantly higher in the above-normal TSH group than in the lower-normal TSH group (OR 1.58, 95% CI 1.02-2.45, p = 0.04).
CONCLUSIONS: Our data indicate that higher TSH concentrations are positively correlated with CKD prevalence and that a high TSH concentration is a risk factor for CKD development.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Chronic kidney disease; Risk factor; Thyrotropin

Mesh:

Substances:

Year:  2019        PMID: 30799424     DOI: 10.1159/000497326

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

Review 1.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

2.  Subclinical hypothyroidism is associated with albuminuria in Japanese nondiabetic subjects.

Authors:  Akiko Toda; Shigeko Hara; Hiroshi Tsuji; Yasuji Arase
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

3.  Prevalence of hypothyroidism among chronic kidney disease patients in security force hospital (SFH) in Saudi Arabia.

Authors:  Faisal Alshammari; Sultan Alhazaa; Abdullah Althemery; Fahad Alsabaan; Abdulelah AlGosaibi; Manal Alshammari; Ali Aldabies; Mohammad Alfifi
Journal:  J Family Med Prim Care       Date:  2019-10-31

Review 4.  The Interplay Between Thyroid Dysfunction and Kidney Disease.

Authors:  Yoko Narasaki; Peter Sohn; Connie M Rhee
Journal:  Semin Nephrol       Date:  2021-03       Impact factor: 5.299

5.  Thymoquinone Upregulates Catalase Gene Expression and Preserves the Structure of the Renal Cortex of Propylthiouracil-Induced Hypothyroid Rats.

Authors:  Nasra Ayuob; Maha Jameal Balgoon; Ahmed A El-Mansy; Wafaa A Mubarak; Alaa El-Din L Firgany
Journal:  Oxid Med Cell Longev       Date:  2020-07-20       Impact factor: 6.543

6.  Thyroid Feedback Quantile-based Index correlates strongly to renal function in euthyroid individuals.

Authors:  Sijue Yang; Shuiqing Lai; Zixiao Wang; Aihua Liu; Wei Wang; Haixia Guan
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.